Irska - angleščina - HPRA (Health Products Regulatory Authority)

bausch health ireland limited - lidocaine hydrochloride; fluorescein sodium - eye drops, solution - 4%w/v +0.25 percent weight/volume - colouring agents; fluorescein, combinations

Irska - angleščina - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - fluorescein sodium - eye drops solution - 1 %w/v - fluorescein

Irska - angleščina - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - fluorescein sodium - eye drops solution - 2.0 %w/v - fluorescein

Združene države Amerike - angleščina - NLM (National Library of Medicine)

nomax inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - fluorescein 1 mg - for staining the anterior segment of the eye in disclosing corneal injury, in applanation tonometry and when fitting contact lenses.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

remedyrepack inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - fluorescein 1 mg in 1 mg

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

bausch & lomb (nz) ltd - fluorescein sodium 0.25%{relative};  ; lidocaine hydrochloride monohydrate 4%{relative};   - eye drops, solution - active: fluorescein sodium 0.25%{relative}   lidocaine hydrochloride monohydrate 4%{relative}   excipient: hydrochloric acid povidone water for injection

Kanada - angleščina - Health Canada

bausch & lomb inc - fluorescein sodium; benoxinate hydrochloride - solution - 0.25%; 0.4% - fluorescein sodium 0.25%; benoxinate hydrochloride 0.4% - local anesthetics

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

serb sa-nv - fluorescein sodium 100 mg/ml - solution for injection - fluorescein sodium 100 mg/ml - fluorescein

Združene države Amerike - angleščina - NLM (National Library of Medicine)

altaire pharmaceuticals inc. - benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303), fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - benoxinate hydrochloride 4 mg in 1 ml - altafluor benox (fluorescein sodium and benoxinate hydrochloride ophthalmic solution) 0.25%/0.4% is indicated for ophthalmic procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. altafluor benox is contraindicated in patients with known hypersensitivity to any component of this product. risk summary   there are no available data on the use of altafluor benox in pregnant women to inform any drug associated risk. adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. altafluor benox should be given to a pregnant woman only if clearly needed. risk summary    there are no data on the presence of fluorescein sodium or benoxinate hydrochloride in human milk after ocular administration of altafluor benox, the effects on the breastfed infant, or the effects on milk production. the developmental and health benefits of breastfeeding should be considered, along with the mother’s clinical need for altafluor benox a

Združene države Amerike - angleščina - NLM (National Library of Medicine)

ocusoft, inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), proparacaine hydrochloride (unii: u96ol57goy) (proparacaine - unii:b4ob0jhi1x) - for procedures requiring a disclosing agent in combination with an anesthetic agent such as tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures. known hypersensitivity to any component of this product.